AdultFriendFinder Reviews: Is It Worth It? Website Overview, Pricing, Pros and Cons - TigersOfTinder AFF Review
April 23, 2021 05:28 ET | TigersofTinder
SAN DIEGO, April 23, 2021 (GLOBE NEWSWIRE) -- AdultFriendFinder is one of the largest US-based adult dating sites; it has over 80 million members worldwide. It's open to both paying and non-paying...
TruthFinder Review: Company Overview, Pros, Cons, and Features Comparison
April 23, 2021 03:13 ET | Magnolia Media Network
SAN DIEGO, April 23, 2021 (GLOBE NEWSWIRE) -- MagnoliaMedia announces the release of the report “TruthFinder Review” There are numerous background check services online, but it is hard to find one...
15 Best Dating Sites and Apps in 2021: List of the Top Online Dating Platforms by Type
April 23, 2021 02:49 ET | TigersofTinder
SAN DIEGO, April 23, 2021 (GLOBE NEWSWIRE) -- announces the release of the review, “Best Dating Sites in 2021” Dating sites and apps are numerous nowadays and asking someone...
AABB logo.png
Asia Broadband Plans Legal Action Against Misleading Internet Posts
April 13, 2021 18:25 ET | Asia Broadband Inc.
LAS VEGAS, April 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) announced today that the Company is planning legal action against numerous...
Better Email Logo.jpg
Strategic Tax Leaders are Preparing Now for Tax Reform 2.0
October 16, 2018 09:15 ET | PowerPlan Inc.
ATLANTA, Oct. 16, 2018 (GLOBE NEWSWIRE) -- This year organizations adjusted their tax approach due to the passing of the Tax Cuts and Jobs Act. Strategic tax teams are continuing to prepare for...
Hemispherx Biopharma Reports Article by Senior Authors From Italian Ministry of Health and Related Agencies Suggesting Broad Applicability of Ampligen(R) to Multiple Sclerosis
September 23, 2015 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today a new peer reviewed article, with senior authors from the Italian Ministry of Health and other...
Generex Biotechnology Corp. Logo
The International Journal of Cancer Publishes Studies on the Anti-Cancer Activity of Generex Biotechnology's Immunotherapeutic Vaccine
July 31, 2007 08:00 ET | Generex Biotechnology Corp.
WORCESTER, Mass., July 31, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today publication in the peer-reviewed International Journal of Cancer (published online...